University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27514, United States
NCT Number: NCT04432753
This online randomized controlled trial seeks to determine if inclusion of incidental findings information in a lung cancer screening decision aid affects screening intent among screening-eligible individuals. Participants will view either a decision aid with incidental findings information or without and indicate their intent to pursue lung cancer screening.
Hypothesis: Inclusion of incidental findings in a decision aid will decrease intent to screen among participants.
Looking for future studies?
Notify Me55 year–80 year
All sexes
Interventional
Not applicable
Chapel Hill, North Carolina, 27514, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention consists of a previously tested and developed brief lung cancer screening video decision aid with the addition of information on incidental findings for lung cancer screening.
The intervention consists of a previously tested and developed brief lung cancer screening video decision aid that does not include information on incidental findings.
Time frame: Day 1
This will be assessed by a survey item where participants indicate their response to a statement of whether they plan to pursue lung cancer screening, with answer choices being strongly agree, agree, disagree and strongly disagree. Comparison between the intervention and control groups will be made.
Time frame: Day 1
Lung cancer screening knowledge tested by 6 multiple choice questions on facts of the benefit and harms of screening. The questions will be answered before and after participants watch a lung cancer screening decision aid. Scores will be determined by the number of correct answers for questions.
Time frame: Day 1
Participants will rate (Likert 1-5 scale with 1 being less important and 5 being more important) 6 lung cancer screening benefits and harms on importance to them.
Time frame: Day 1
Participants will rank six lung cancer screening benefits and harms.
Time frame: Day 1
Participants will rank six lung cancer screening benefits and harms.
Time frame: Day 1
Participants will rank six lung cancer screening benefits and harms.
Time frame: Day 1
Participants will rank six lung cancer screening benefits and harms, including one on incidental findings. Comparison of mean ranking will be made between the intervention and control groups.
UNC Lineberger Comprehensive Cancer Center
Other
Effect of Incidental Findings Information on Lung Cancer Screening Intent: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04314895
Bronchial Neoplasms, Carcinoma, Bronchogenic
Gainesville, Florida, United States
View Trial DetailsNCT04566614
Biliary Tract Diseases, Biliary Tract Neoplasms
Sutton, Surrey, United Kingdom
View Trial DetailsNCT03123783
Cancer, Lung Diseases
Tucson, Arizona, United States
View Trial DetailsNCT04665531
Lung Diseases, Lung Neoplasms
Golnik, Slovenia
View Trial Details